Clinical and Genetic Analysis of KATP Variants With Heart Failure Risk in Patients With Decreased Serum ApoA-I Levels.
Cheng LiuYanxian LaiJingxian PeiHuiling HuangJunfang ZhanSongsong YingYan ShenPublished in: The Journal of clinical endocrinology and metabolism (2021)
KATP rs141294036 was associated with increased risks of lower ApoA-I levels, HF incidence (especially HFpEF), and HF rehospitalization in those with the 5 confirmed exo-miRs and its related metabolic pathways.